Cannabis and Prescription Drug Use Among Older Adults With Functional Impairment.
Cannabis and Prescription Drug Use Among Older Adults With Functional Impairment.
复制标题
DOI:
10.1016/j.amepre.2021.01.042
复制
发表时间:
2021-08
影响因子:
5.5
通讯作者:
Palamar JJ
中科院分区:
文献类型:
--
作者:
Han BH;Le A;Funk-White M;Palamar JJ
Psychoactive substance use may be risky for adults with functional impairments. This study investigates cannabis use and prescription opioid and tranquilizer/sedative (mis)use among adults aged ≥50 years reporting functional impairments in the U.S. This cross-sectional analysis of adults aged ≥50 years from the 2015–2019 cohorts of the National Survey on Drug Use and Health estimates the prevalence of past-year medical and nonmedical cannabis use, and prescription opioid and tranquilizer/sedative use and misuse, according to the number of functional impairments reported. The adjusted odds of medical and nonmedical use or misuse of each substance in relation to any impairment, number of impairments, and specific impairments were estimated using logistic regression. Analyses were conducted in December 2020. Compared with those reporting no impairments, those reporting any impairment were more likely to report use of cannabis and (mis)use of prescription opioids and tranquilizers/sedatives (all p<0.05). Prevalence of (mis)use increased for each drug as number of impairments increased (all p<0.001). Having any impairment was associated with increased odds for medical cannabis use (AOR=2.28, 95% CI=1.57, 3.30) but not nonmedical use, and increased odds for misuse of prescription opioids (AOR=1.62, 95% CI=1.38, 1.91) and tranquilizers/sedatives (AOR=1.59, 95% CI=1.20, 2.11). Impaired thinking was associated with increased odds for use and misuse of each substance, and impaired ability to do errands was associated with increased odds for prescription opioid misuse (AOR=1.34, 95% CI=1.01, 1.78). Prescription drug misuse is linked to functional impairments among adults aged ≥50 years and may pose a potential risk for this vulnerable population.
登录
查看更多内容
影响因子:
4.4
作者:
Ford, Jason A.;Hinojosa, Melanie Sberna;Nicholson, Harvey L.
通讯作者:
Nicholson, Harvey L.
影响因子:
4.1
作者:
Gaugler, Joseph E;Duval, Sue;Anderson, Keith A;Kane, Robert L
通讯作者:
Kane, Robert L
影响因子:
3.3
作者:
Han, Benjamin H.;Moore, Alison A.
通讯作者:
Moore, Alison A.
DOI:
10.1016/j.ssmph.2017.12.005
发表时间:
2018-04
期刊:
SSM - population health
影响因子:
--
作者:
Backe IF;Patil GG;Nes RB;Clench-Aas J
通讯作者:
Clench-Aas J
影响因子:
6.3
作者:
Yang KH;Kaufmann CN;Nafsu R;Lifset ET;Nguyen K;Sexton M;Han BH;Kim A;Moore AA
通讯作者:
Moore AA